In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 25 | Yes |
Popular Name: Clotrimazole Clotrimazole
Find On: PubMed — Wikipedia — Google
CAS Numbers: 23593-75-1 , [23593-75-1]
1-[(2-Chloro-phenyl)-diphenyl-methyl]-1H-imidazole
23593-75-1; C06922; Clotrimazole
23593-75-1; Clotrimazole (JP16/USP/INN); D00282; Lotrimin (TN); Mycelex (TN)
23593-75-1; Clotrimazole; Prestwick_120
3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591
Canesten 1-Day Cream Combi-Pak
Canesten Combi-Pak 1-Day Therapy
Canesten Combi-Pak 3-Day Therapy
Clotrimazole [USAN:INN:BAN:JAN]
CLOTRIMAZOLE; CPD000058306; SAM001247056
CPD-8926; clotrimazol; clotrimeizol
CPD000058306; CLOTRIMAZOLE; 23593-75-1
Gyne-Lotrimin 3 Combination Pack
Gyne-Lotrimin Combination Pack
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.47 | 13.43 | -5.78 | 0 | 2 | 0 | 18 | 344.845 | 4 | ↓ |
Mid Mid (pH 6-8) | 5.47 | 13.99 | -28.18 | 1 | 2 | 1 | 19 | 345.853 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.47e-03 g/l | DrugBank-approved |
Target | Antifection | Selleck Chemicals |
Therapy | antifungal | SMDC Iconix |
biological_use | Antifungal agent | IBScreen Bioactives |
mechanism | Appears to increase permeability of fungal-cell-membrane causing leakage of intracellular components. | IBScreen Bioactives |
UniProt Database Links | CP121_MYCTU; CP46A_HUMAN; GAO_CICIN; MOD5_YEAST | ChEBI |
Patent Database Links | EP0862917; EP1229034; EP1514877; EP1639994; EP1652535; EP1685843; EP1688161; EP1712220; EP1754481; EP1810695; EP1849463; EP1857113; EP1864657; EP1894559; EP1911454; EP1925316; EP1958613; EP1970076; US2004198669; US2004254182; US2004261190; US2005020587; U | ChEBI |
mechanism | Functions as Lanosterol C-14 demethylation inhibitor | IBScreen Bioactives |
mechanism | Induces K+ release from Trichophyton mentagrophytes mycelium | IBScreen Bioactives |
mechanism | Induces membrane disruption | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 101397 | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
mechanism | Potent cytochrome P-450b and P-450c inhibitor | IBScreen Bioactives IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 101397 | NIH Clinical Collection via PubChem |
Purity | USP23 | APIChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AMPC-1-B | Beta-lactamase (cluster #1 Of 6), Bacterial | Bacteria | 6 | 0.46 | Binding ≤ 10μM |
CP51-1-B | Sterol 14-alpha Demethylase (cluster #1 Of 2), Bacterial | Bacteria | 200 | 0.38 | Binding ≤ 10μM |
CP17A-1-E | Cytochrome P450 17A1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 82 | 0.40 | Binding ≤ 10μM |
CP19A-3-E | Cytochrome P450 19A1 (cluster #3 Of 3), Eukaryotic | Eukaryotes | 2 | 0.49 | Binding ≤ 10μM |
CP51A-1-E | Cytochrome P450 51 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 130 | 0.39 | Binding ≤ 10μM |
KCNA3-1-E | Voltage-gated Potassium Channel Subunit Kv1.3 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 6000 | 0.29 | Binding ≤ 10μM |
KCNH2-5-E | HERG (cluster #5 Of 5), Eukaryotic | Eukaryotes | 3020 | 0.31 | Binding ≤ 10μM |
KCNN4-1-E | Intermediate Conductance Calcium-activated Potassium Channel Protein 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 70 | 0.40 | Binding ≤ 10μM |
MDHM-1-E | Malate Dehydrogenase, Mitochondrial (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2 | 0.49 | Binding ≤ 10μM |
MDR1-1-E | P-glycoprotein 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6700 | 0.29 | Functional ≤ 10μM |
MDR3-1-E | P-glycoprotein 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4800 | 0.30 | Functional ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 50 | 0.41 | ADME/T ≤ 10μM |
Q96W81-1-F | 14-alpha Sterol Demethylase (cluster #1 Of 1), Fungal | Fungi | 103 | 0.39 | Binding ≤ 10μM |
Q4WNT5-1-O | 14-alpha Sterol Demethylase Cyp51A (cluster #1 Of 1), Other | Other | 4790 | 0.30 | Binding ≤ 10μM |
Z50380-1-O | Mycobacterium Smegmatis (cluster #1 Of 4), Other | Other | 6540 | 0.29 | Functional ≤ 10μM |
Z50425-9-O | Plasmodium Falciparum (cluster #9 Of 22), Other | Other | 60 | 0.40 | Functional ≤ 10μM |
Z50426-1-O | Plasmodium Falciparum (isolate K1 / Thailand) (cluster #1 Of 9), Other | Other | 250 | 0.37 | Functional ≤ 10μM |
Z80682-8-O | A549 (Lung Carcinoma Cells) (cluster #8 Of 11), Other | Other | 5100 | 0.30 | Functional ≤ 10μM |
Z80951-2-O | NIH3T3 (Fibroblasts) (cluster #2 Of 4), Other | Other | 630 | 0.35 | Functional ≤ 10μM |
Z80936-1-O | HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other | Other | 3000 | 0.31 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q96W81_ASPFM | Q96W81 | 14-alpha Sterol Demethylase, Aspfm | 103 | 0.39 | Binding ≤ 1μM |
AMPC_ECOLI | P00811 | Beta-lactamase, Ecoli | 24 | 0.43 | Binding ≤ 1μM |
CP17A_HUMAN | P05093 | Cytochrome P450 17A1, Human | 81.5 | 0.40 | Binding ≤ 1μM |
CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 1.8 | 0.49 | Binding ≤ 1μM |
CP51A_HUMAN | Q16850 | Cytochrome P450 51, Human | 130 | 0.39 | Binding ≤ 1μM |
KCNN4_HUMAN | O15554 | Intermediate Conductance Calcium-activated Potassium Channel Protein 4, Human | 360 | 0.36 | Binding ≤ 1μM |
CP51_MYCTU | P0A512 | Lanosterol 14-alpha Demethylase, Myctu | 200 | 0.38 | Binding ≤ 1μM |
MDHM_PIG | P00346 | Malate Dehydrogenase Mitochondrial, Pig | 2 | 0.49 | Binding ≤ 1μM |
Q96W81_ASPFM | Q96W81 | 14-alpha Sterol Demethylase, Aspfm | 103 | 0.39 | Binding ≤ 10μM |
Q4WNT5_ASPFU | Q4WNT5 | 14-alpha Sterol Demethylase Cyp51A, Aspfu | 4790 | 0.30 | Binding ≤ 10μM |
AMPC_ECOLI | P00811 | Beta-lactamase, Ecoli | 24 | 0.43 | Binding ≤ 10μM |
CP17A_HUMAN | P05093 | Cytochrome P450 17A1, Human | 81.5 | 0.40 | Binding ≤ 10μM |
CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 1.8 | 0.49 | Binding ≤ 10μM |
CP51A_HUMAN | Q16850 | Cytochrome P450 51, Human | 130 | 0.39 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3019.95172 | 0.31 | Binding ≤ 10μM |
KCNN4_HUMAN | O15554 | Intermediate Conductance Calcium-activated Potassium Channel Protein 4, Human | 360 | 0.36 | Binding ≤ 10μM |
CP51_MYCTU | P0A512 | Lanosterol 14-alpha Demethylase, Myctu | 200 | 0.38 | Binding ≤ 10μM |
MDHM_PIG | P00346 | Malate Dehydrogenase Mitochondrial, Pig | 2 | 0.49 | Binding ≤ 10μM |
KCNA3_HUMAN | P22001 | Voltage-gated Potassium Channel Subunit Kv1.3, Human | 6000 | 0.29 | Binding ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 5100 | 0.30 | Functional ≤ 10μM |
Z50380 | Z50380 | Mycobacterium Smegmatis | 6540 | 0.29 | Functional ≤ 10μM |
Z80951 | Z80951 | NIH3T3 (Fibroblasts) | 630 | 0.35 | Functional ≤ 10μM |
MDR1_HUMAN | P08183 | P-glycoprotein 1, Human | 1300 | 0.33 | Functional ≤ 10μM |
MDR1_MOUSE | P06795 | P-glycoprotein 1, Mouse | 3500 | 0.31 | Functional ≤ 10μM |
MDR3_MOUSE | P21447 | P-glycoprotein 3, Mouse | 4800 | 0.30 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 250 | 0.37 | Functional ≤ 10μM |
Z50426 | Z50426 | Plasmodium Falciparum (isolate K1 / Thailand) | 250 | 0.37 | Functional ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 20 | 0.43 | ADME/T ≤ 10μM |
Z80936 | Z80936 | HEK293 (Embryonic Kidney Fibroblasts) | 3000 | 0.31 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Abacavir transmembrane transport | |
ABC-family proteins mediated transport | |
Activation of gene expression by SREBF (SREBP) | |
Aflatoxin activation and detoxification | |
Androgen biosynthesis | |
Ca2+ activated K+ channels | |
Cholesterol biosynthesis | |
Endogenous sterols | |
Estrogen biosynthesis | |
Glucocorticoid biosynthesis | |
Voltage gated Potassium channels | |
Xenobiotics |